Antioxidant and pharmacodynamic effects of pyridoindole stobadine

General Pharmacology

Volumn 30, Issue 5, 1998, Pages 627-638

  Horáková, L' ^a   Stolc S ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Antioxidant; Cardioprotection; Clinical trials; Free oxygen radical scavenger; Hypoxia reoxygenation; Ischemia reperfusion; LDL; Neuroprotection; Oxidative stress; Pharmacodynamics; Pharmacokinetics; Pyridoindole; Stobadine; Toxicity

Indexed keywords

ANTIOXIDANT; CARBOLINE DERIVATIVE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGEN RADICAL; SCAVENGER; STOBADINE;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; DRUG EFFECT; DRUG TOLERANCE; HEART INFARCTION; HEART PROTECTION; HUMAN; IN VITRO STUDY; LIPID PEROXIDATION; NEUROPROTECTION; OXIDATIVE STRESS; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; TOXICOLOGY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BIOTRANSFORMATION; CARBOLINES; CLINICAL TRIALS; HEMODYNAMIC PROCESSES; HISTAMINE H1 ANTAGONISTS; HUMANS; ION CHANNELS; ION PUMPS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXIDATION-REDUCTION; PERIPHERAL NERVES; REACTIVE OXYGEN SPECIES;

EID: 0345676510     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00300-5     Document Type: Review

References (133)

1. Babinská M., Majerčík M., Plačková S., Mazúrová E., Babul'ová A. Subchronic toxicity of pyridoindole derivative. biochemical and hematological parameters (in Slovak) Čs. Fyziol. 33:1984;138.
2. Babul'ová A., Buran L', Beneš L. The influence of some pyridoindole derivatives on epinephrine arrhythmia in guinea-pigs after oral administration (in Slovak). Farm. Obzor. 54:1985;15-20.
3. Balonová T., Zeljenková D. Reproductive and teratological studies with a pyridoindole derivative I. effect on fertility and general reproductive performance of the rat Tichý M. QSAR in Toxicity and Xenobiochemistry Vol. 8. 1985;373-378 Elsevier, Amsterdam. Pharmacochemistry Library.
4. Balonová T., Ujházy E., Nosál' R., Ďurišová M., Jakubovský J., Liška J. Effect of the cardioprotective agent stobadine on reproduction in rats. Bratisl. Lek. Listy. 92:1991;603-608. . a.
5. Balonová T., Zeljenková D., Ďurišová M., Nosál' R., Jakubovský J., Liška J., Štolc S. Reproductive toxicity study with cis-(-)2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3-b] indole in rats. Arzneim. Forsch. Drug Res. 41:1991;1-5. . b.
6. Barkov N. K. Contribution to the mechanisms of action of carbidine (in Russian). Farmak. Toksikol. 36:1973;154-157.
7. 2-adrenoceptor and ATP-receptor activation. Gen. Physiol. Biophys. 1:1982;175-188. . a.
8. Bauer V. Distribution and types of adrenoceptors in the guinea-pig ileum. the activation of alpha- and beta-adrenoceptor blocking agents Br. J. Pharmac. 76:1982;569-578. . b.
9. Bauer V. and Štolc S. (1980) Antiarrhythmic effect of carbidine II: adrenaline induced arrhythmias in guinea-pigs (in Slovak). In Zborník Prác ÚEF SAV, (Edited by Beneš L.), Vol. 2, pp. 337-345. Veda Bratislava.
10. Bauer V. and Štolc S. (1985) Effect of pyridoindoles on smooth muscle and peripheral nerves (in Slovak). In Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium, pp. 370-415. Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
11. Bauer V., Štolc S. and Dugátová M. (1980) Effect of carbidine on smooth muscle and peripheral nerves (in Slovak). In Zborník Prác ÚEF SAV, (Edited by Beneš L.), Vol. 2, pp. 297-320. Veda Bratislava.
12. Bauer V., Štolc S. and Beneš L. (1982) New antiarrhythmic drug with pyridoindole structure II. In Symposium on the Pharmacology of the Cardiovascular System, 30 August-1 September, Abstract book, p. 5. Tatranské Mlynčeky, Czechoslovak Pharmac. Soc., Bratislava.
13. Bauer V., Buran L. and Babul'ová A. (1990) Action of stobadine on respiratory and vascular muscle in vivo: evidence for histamine receptor antagonist activity. Arch. Int. Pharmacodyn. 304, 232-246.
14. Beneš L., Štolc S. Stobadine. Drugs Future. 14:1989;135-137.
15. Benešová O., Tejkalová H., Krištofíková Z., Němcová V., Řípová D. and Klaschka J. (1993) Experimental study of potential nootropic effect of stobadine (Slovakofarma) in comparison with sabeluzole (Janssen). In 35th Psychofarmakol. konf, pp. 1-14. Cs. Psychiatric Soc., Prague, Jeseník, Czech Republic.
16. Bezáková Ž, Blešová M., Bachratá M. Stobadine hydrochloride. study of physical and chemical properties and stability of agent (in Slovak) Farm. Obzor. 62:1993;247-252.
17. 2 blockers on histamine-induced contraction of guinea pig airways in vitro. Respiration. 57:1990;104-108.
18. Buran L', Bauer V., Babul'ová A. Contribution to the characterization of the antihistaminic effect of DH 1011 (in Slovak). Čs. Fyziol. 36:1987;223.
19. Cerutti P. A., Fridovich I., McCord J. M. Oxy-radicals in Molecular Biology and Pathology. 1988;Liss, New York.
20. Chalupa I., Blaško M., Beneš L. In vitro micronucleus test of the cardioprotective agent stobadine. a genotoxicological study Pharmazie. 48:1993;206-207.
21. Chorvatovičová D. Radioprotective effect of stobadine in the mouse micronucleus test. Mutat. Res. 324:1994;7-11.
22. Chorvatovičová D., Bauer V. Stobadine. inhibitor of cyclophosphamide-induced micronuclei in mice Mutagenesis. 9:1994;241-244.
23. Chorvatovičová D., Ujházy E. Transplacental effect of stobadine on cyclophosphamide-induced micronucleus frequency in mice. Mutagenesis. 10:1995;531-534.
24. Clinch K. A., Vincenzi F. F., Rohn T. T., Hinds T. R. Stobadine protects ion pump ATPases from free radical inhibition. Proc. West. Pharmac. Soc. 36:1993;209-214.
25. Cowden W. B., Lewis-Hughes P. H., Clark I. A. Protection against alloxan-induced diabetes in mice by the free radical scavenger butylated hydroxyanisole. Biochem. Pharmac. 34:1985;3601-3603.
26. DeFlora S., Ramel C. Mechanisms of inhibitors of mutagensis and carcinogenesis. classification and overview Mutat. Res. 202:1988;285-306.
27. Dittertová V. Acute toxicity of selected pyridoindole derivatives (in Slovak). Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium. 1985;638-647 Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
28. Dittertová V., Štolc S., Beneš L., Bilčíková L., Bauer V. Some central effects of the pyridoindole derivatives (in Slovak). Čs. Fyziol. 36:1987;223.
29. Domány Gy., Gere A., Paróczai M., Schön I., Szántay Cs. Jr., Bihari M., Hegedüs B., Kiss B., Kárpáti E., Szántay Cs. Acylated pyrimido[1',6',1,2]pyrido[3,4-b] indoles as potential cerebroprotectants. Mózsik Gy., Emerit I., Fehér J., Matkovics B., Vincze Á. Oxygen Free Radicals and Scavengers in the Natural Sciences. 1993;109-112 Akadémiai Kiadó Budapest.
30. Domeyer B. E., Sládek N. E. Kinetics of cyclophosphamide biotransformation "in vivo" Cancer Res. 40:1980;174-180.
31. Drábiková K., Pečivová J., Nosál' R. Effect of stobadine on stimulated isolated mast cells. Agents Actions. 23:1988;188-190.
32. 3H stobadine in individual parts of rat brain (in Slovak). Book of Abstracts, 14th Biochemical Days. 1995;113 CHTF STU, Bratislava.
33. Dubovický M., Kovačovský P., Rychlík I., Ujházy E., Gajdošík A. Effect of long-term administration of stobadine to rats on selective parameters of spontaneous behaviour of their offspring. Gen. Physiol. Biophys. 15:1996;181-186.
34. Dzúrik R., Fedelešová V. Report on the clinical study of the preparation stobadine in volunteers. a single administration (in Slovak) Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium. 1987;2358-2369 Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
35. Dzúrik R., Bojar Z., Fedelešová V., Bielická Z. Report on the study of psychological action of stobadine in volunteers. a single administration (in Slovak) Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium. 1987;2384-2421 Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
36. Dzúrik R., Gerová Z., Molitorisová M. Report on the clinical-pharmacological study of the stobadine preparation in capsules. a one month, single open trial (in Slovak) Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium. 1987;2434-2453 Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
37. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL (review article). Free Radical Biol. Med. 13:1992;341-390.
38. Gabauer I., Styk J., Slezák J., Okoličány J., Holec V., Beneš L. Effect of DH 1011 (stobadine) on myocardial blood flow and infarct size after experimental coronary occlusion (in Slovak). Bratisl. Lek. Listy. 85:1986;265-273.
39. Gajdošík A., Ujházy E., Gajdošíková A., Tomášková A., Liška J., Vargová T., Balónová T. A chronic, 180 day toxicity of stobadine (DP1031) in rats (in Slovak). Čs. Fyziol. 42:1993;146.
40. Gajdošíková A., Ujházy E., Gajdošík A., Chalupa I., Blaško M., Tomášková A., Liška J., Dubovický M., Bauer V. Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneim.-Forsch. Drug Res. 45:1995;531-536.
41. Gibala P., Kittová M., Sotníková R., Knezl V., Dřímal J., Beneš L. On the antiarrhythmic activity of (-)-cis 2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-4,3b-indole (DH 1011). In. Abstracts from International Symposium on Pharmacological Stabilization of Excitable Membranes:1984;28. Smolenice, Czechoslovakia.
42. Gibala P., Sotníková R., Dřímal J. Antiarrhythmic activity of the substance DH 1011. Bratisl. Lek. Listy. 84:1985;137-144.
43. Halliwell B. Lipid Peroxidation, Free-Radical Reactions and Human Disease. Current Concepts:1991;Upjohn, Kalamazoo, MI.
44. Heikkila R. E. The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Eur. J. Pharmac. 44:1977;191-193.
45. Heikkila R. E., Winston B., Cohen G., Bardew H. Alloxan-induced diabetes. evidence for hydroxyl radical as a cytotoxic intermediate Biochem. Pharmac. 25:1976;1085-1092.
46. Horáková L', Juránek I., Bokníková B. Antioxidative effect of stobadine on lipid peroxidation of rat brain mitochondria. Biológia (Bratislava). 45:1990;313-318. . a.
47. Horáková L', Lukovič L', Štolc S. Effect of stobadine and vitamin E on the ischemic reperfused brain tissue. Pharmazie. 45:1990;223-224. . b.
48. Horáková L', Uraz V., Ondrejičková O., Lukovič L., Juránek I. Effect of stobadine on brain lipid peroxidation induced by incomplete ischemia and subsequent reperfusion. Biomed. Biochim. Acta. 50:1991;1019-1025.
49. Horáková L', Briviba K., Sies H. Antioxidant activity of the pyridoindole stobadine in liposomal and microsomal lipid peroxidation. Chem. Biol. Interact. 83:1992;85-93. . a.
50. Horáková L', Ondrejičková O., Uraz V., Lukovič L., Juránek I. Short cerebral ischemia and subsequent reperfusion and treatment with stobadine. Experientia. 48:1992;872-874. . b.
51. Horáková L', Sies H., Steenken S. Antioxidant action of stobadine. Packer L. Methods in Enzymology Vol. 234. 1994;572-581 Part D, pp. Academic Press, San Diego.
52. Horáková L', Schaur R. J., Balgavý P., Egger G. Interaction of the pyridoindole stobadine with alkoxyl and stable free radicals. Redox Rep. 1:1995;369-372.
53. ++-mediated oxidation of low-density lipoprotein. Biochem. Pharmac. 51:1996;1277-1282. . a.
54. Horáková L', Schaur R. J., Balgavý P. The crocin assay for the determination of relative rate constants of alkoxyl radical reactions with the pyridoindole stobadine and with other antioxidants. Redox Rep. 2:1996;401-405. . b.
55. Horáková L', Štolc S., Chromíková Z., Pekárová A., Derková L'. Mechanisms of hippocampal reoxygenation injury. treatment with antioxidants Neuropharmacology. 36:1997;177-184.
56. Horváthová E., Slameňová D., Chorvatovičová D., Wsólová L. Assessment of antimutagenic effects of stobadine dihydrochloride on MNNG-induced mutations in Chinese hamster cell V79. Neoplasma. 42:1995;259-264.
57. Hudecová S., Ondrejičková O., Beneš L. A study of myocyte stabilization in the impaired rat myocardium by following thiols levels (in Slovak). Čs. Fyziol. 32:1983;141.
58. Humplová J., Štefek M., Beneš L., Križanová L. Interaction of stobadine with superoxide in vitro (in Slovak). Čs. Fyziol. 41:1992;80.
59. Kagan V. E., Tsuchiya M., Serbinova E., Packer L., Sies H. Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem. Pharmac. 45:1993;393-400.
60. Kállay Z., Bittererová J., Brejcha A., Fáberová V., Bezek S., Trnovec T. Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis-(-)-2,3,4,4a,5,9b-hexahydro-2, 8-dimethyl-1H-pyrido-[4,3b] indole dihydrochloride in rats. Arzneim.-Forsch. Drug Res. 40:1990;974-979.
61. Kállay Z., Šoltés L., Trnovec T. Pharmacokinetics of stobadine and of the sum of its metabolites in rats during repeated administration. Biopharm. Drug Dispos. 12:1991;201-205.
62. Kaplán P., Račay P., Lehotský J., Mézešová V. Change in fluidity of brain endoplasmic reticulum membranes by oxygen free radicals. a protective effect of stobadine, alpha-tocopherol acetate, and butylated hydroxytoluene Neurochem. Res. 20:1995;815-820.
63. Kittová M., Gibala M., Dřímal J. Antiarrhythmic and hemodynamic effects of pyridoindole derivative (DH 1011) in experimental models of heart rhythm and function disturbances (in Slovak). Bratisl. Lek. Listy. 84:1985;542-556.
64. Knezl V. Effect of stobadine on rat heart dysrhythmias induced by ischemia/reperfusion (in Slovak). Čs. Fyziol. 44:1995;37.
65. Kovács P., Baricová L., Koval'ová M., Dostál J., Stankovičová T., Švec P. Modification of reperfusion dysrhythmias by pharmacological means (in Slovak). Čes. Slov. Farm. 44:1995;257-260.
66. Krištofová A., Ujházy E., Bezek S., Balonová T., Nosál' R. Stobadine toxicity and transplacental movement. Arch. Toxicol. Suppl. 14:1991;280-284.
67. Kukan M., Bezek Š, Trnovec T., Gabauer L., Styk J. On the absorption of drug using chronic dog ileal loop method. Methods Find. Exp. Clin. Pharmac. 16:1994;437-442.
68. Kvaltínová Z. and Štolc S. (1993) Effect of stobadine on N-methyl-D-aspartate binding sites in rat hippocampus under oxidative stress. In Trends in Drug Research, the abstract book of the ninth Noordwijkerhout-Camerino Symposium, 23-27 May, p. 29. Noordwijkerhout, The Netherlands.
69. Kvaltínová Z., Štolc S. NMDA binding sites in rat hippocampus under oxidative stress. effect of antioxidants and NMDA antagonists Ann. N. Y. Acad. Sci. 812:1997;240-242.
70. 1-adrenoceptor blocking action of DH 1011. J. Pharmac. (Paris). 17:1986;187.
71. Kvaltínová Z., Lukovič L., Štolc S. Effect of incomplete ischemia and reperfusion of the rat brain on the density and affinity of alpha-adrenergic binding sites in the cerebral cortex. prevention of changes by stobadine and vitamin E Neuropharmacology. 32:1993;785-791.
72. Lissi E. A., Faure M., Montoya N., Videla L. A. Reactivity of indole derivatives towards oxygenated radicals. Free Radical Biol. Commun. 15:1991;211-222.
73. Lukáčová N., Chavko M., Halát G. Effect of stobadine on lipid peroxidation and phospholipids in rabbit spinal cord after ischemia. Neuropharmacology. 32:1993;235-241.
74. Lukovič L., Machová J. Antihistaminic activity of stobadine in the peripheral and central nervous system. Agents Actions. 23:1988;257-259.
75. Lysko P. G., Feuerstein G. Z., Ruffolo R. R. Jr. Carvedilol. a novel multiple action antihypertensive drug Pharm. News. 2:1995;12-16.
76. Mačičková T., Navarová J., Hudecová S. and Beneš L. (1983) Comparative study of preventive-repeated and single doses effect of DH 1011 on lysososmal enzymes (abstract). In: Symp. on Lysosomes, Structure and Functions, 1-3 November, p. 57. Smolenice, Czechoslovakia, Czechoslovak Medical Society J.E.P., Bratislava.
77. Majerčík M., Babinská M., Ujházy E., Babul'ová A. and Balonová T. (1984) Six-month toxicity of DP 1031 in beagle dogs (in Slovak). Čs. Fyziol. 33, 171.
78. Matejovičová M., Kaplán P. and Mézešová V. (1995) Synaptosomal plasma membrane from gerbil's brain during oxidative stress in vitro and protective effect of the stobadine. Annual Meeting of the Austrian Neurosci. Assoc., Graz, Austria. p. 72.
79. Metyš J., Metyšová J., Valchář M. and Dlhonožková N. (1985) Effect of stobadine (-)-cis base on nervous system (in Czech). In Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium, pp. 450-475 and 794-796. Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
80. Miháliková K., Ujházy E., Braxatorisová E., Kučera P. Comparative teratological study of stobadine in vivo and in vitro. Toxicol. In Vitro. 7:1993;803-807.
81. Mirossay L., Kohút A. Effect of stobadine on indomethacin- and ethanol-induced stomach lesions and gastric secretion. Physiol. Res. 40:1991;437-440. . a.
82. Mirossay L., Kohút A. Antiulcerogenic effect of pentacaine chlorpromazine and stobadine on ethanol- and indomethacin-induced stomach lesions in rats. Physiol. Res. 40:1991;441-444. . b.
83. Mock A., Ujházy E., Novacký M., Janšák J. Effect of stobadine on prenatal development, behaviour of pregnant rats and their offspring. Biológia (Bratislava). 48:1993;259-265.
84. Mojžiš J., Pomfy M., Kohút A., Beneš L., Nicák A., Mirossay L. Effect of stobadine on gastric mucosal injury after ischemia/reperfusion. Physiol. Res. 45:1996;399-403.
85. Navarová J., Mačičková T., Edelsteinová S. and Beneš L. (1983). Protective effect of DH 1011 on lysosomal enzymes in rat myocardium (abstract). In Symp. on Lysosomes, Structure and Functions, 1-3 November, p. 56. Smolenice, Czechoslovakia, Czechoslovak Medical Society J.E.P., Bratislava.
86. Oberley L. W. Free radicals and diabetes. Free Radical Biol. Med. 5:1988;113-124.
87. Ondrejičková O., Hudecová S., Mačičková T., Sedlák J., Beneš L. Effect of DH 1011 and verapamil on glutathione level in isoprenaline treated rat heart. In. International Symposium on Pharmacological Stabilization of Excitable Membranes:1984;6-8. August, p. 48. Smolenice, Czechoslovakia, Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava.
88. Ondrejičková O., Sedlák J., Mačičková T. and Beneš L. (1987a) Glutathione level, glutathione reductase and catalase activity in responce to hypoxia. In Structure and Mechanisms in Molecular and Quantum Pharmacology, 23-28 August, p. 49. Tatranská Lomnica, Czechoslovakia, Slovak Medical Society, Bratislava.
89. Ondrejičková O., Sedlák J., Mačičková T., Beneš L. Pharmacological influence on lipid peroxidation and the level of endogene antioxidants in isoproterenol induced hypoxia (in Slovak). Bull. Čes. Slov. Spol. Biochem. Mol. Biol. Prague. 15:1987;72. . b.
90. Ondrejičková O., Sedlák J., Mačičková T., Beneš L. Lipid peroxidation and glutathione level in catecholamine induced myocardial hypertrophy (abstract). In: 14th International Congress of Biochemistry:1988;10-15. July, p. 130. Prague, Czechoslovakia, IUB, Prague.
91. Ondrejičková O., Džurba A., Sedlák J., Tokárová J., Mačičková T., Beneš L. Processes linked to the formation of reactive oxygen species are not necessarily involved in the development of isoproterenol-induced hypertrophy of the heart. the effect of stobadine Biomed. Biochim. Acta. 1003:1991;238-245.
92. Ondriaš K., Mišík V., Gergel' D., Staško A. Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadine. Biochim. Biophys. Acta. 1003:1989;238-245.
93. Paróczai M., Gere A., Kárpáti E., Kiss B. Cerebroprotective effect of a new antioxidant agent RG-107710. Mózsik Gy., Emerit I., Fehér J., Matkovics B., Vincze Á. Oxygen Free Radicals and Scavengers in the Natural Sciences. 1993;259-266 Akadémiai Kiadó Budapest.
94. Pavlásek J., Haburčák M., Mašánová C., Štolc S. Transport of an antihypoxic drug stobadine across the blood-brain barrier in rat striatum and its influence on catecholamine-oxidative current. a voltammetric study under normal and anoxic/ischemic conditions Physiol. Res. 45:1996;193-204.
95. Poeggeler B., Reiter R. J., Harderland R., Sewerynek E., Melchiorri D., Barlow-Walden L. R. Melatonin, a mediator of electron transfer and repair reactions, acts synergistically with the chain-breaking antioxidants ascorbate, trolox, and glutathione. Neuroendocrinol. Lett. 17:1995;87-92.
96. Pomfy M., Nicák A., Mojžiš J., Húska J., Beneš L. Experimental studies of some microrrheological factors in serious brain ischemia after stobadine pretreatment. Mol. Chem. Neuropathol. 25:1995;115-122.
97. 2+ transport and protection by stobadine. Biochem. Mol. Biol. Int. 36:1995;569-577.
98. Reiter R. J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:1995;526-533.
99. Reiter R. J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L., Chuang J., Ortiz G. G., Acuňa-Castroviejo D. A review of the evidence supporting melatonine's role as an antioxidant. J. Pineal Res. 18:1995;1-11.
100. Siekel P., Mačičková T., Beňo J. Stobadine. study of mutagenic activity (in Slovak) Čs. Fyziol. 42:1993;147.
101. Singal P. K., Beamish R. E., Dhalla N. S. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart diseases. Spitzer G. G. Myocardial Injury. 1983;391-401 Plenum, New York.
102. Šoltés L., Kállay Z., Bezek S., Fedelešová V. A high performance liquid chromatographic method for the determination of stobadine pharmacokinetics in serum. Biopharm. Drug Dispos. 12:1991;29-35.
103. Sotníková R., Gibala P., Dřímal J. Effect of substance DH 1011 on vascular smooth muscle (in Slovak). Bratisl. Lek. Listy. 84:1985;273-278. . a.
104. Sotníková R., Gibala P., Dřímal J. Alpha-adrenolytic activity of the substance DH 1011 (in Slovak). Bratisl. Lek. Listy. 84:1985;536-541. . b.
105. Stankovičová T., Kovács P., Knezl V., Juránek I., Švec P. Stobadine and trolox c protect the heart against reperfusion-induced dysrhythmias. Fundam. Clin. Pharmac. 10:1996;68.
106. Staško A., Ondriaš K., Mišík V., Szöcsová H., Gergel' D. Stobadine. a novel scavenger of free radicals Chem. Pap. 44:1990;493-500.
107. Steenken S., Sundquist A. R., Jovanovic S. V., Crockett R., Sies H. Antioxidant activity of the pyridoindole stobadine. pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen Chem. Res. Toxicol. 5:1992;355-360.
108. Štefek M., Beneš L. Hydrogen peroxide-dependent liver microsomal N-demethylation and N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent. Xenobiotica. 19:1989;627-634.
109. Štefek M., Beneš L. Pyridoindole stobadine is a potent scavenger of hydroxyl radicals. FEBS Lett. 294:1991;264-266.
110. Štefek M., Trnková Z. Inhibition of alloxan-induced hyperglycemia in mice by the pyridoindole stobadine. Pharmac. Toxicol. 77:1995;320-322.
111. Štefek M., Trnková Z. The pyridoindole antioxidant stobadine prevents alloxan-induced lipid peroxidation by inhibiting its propagation. Pharmac. Toxicol. 78:1996;77-81.
112. Štefek M., Beneš L., Jergelová M., Ščasnár V., Turi-Nagy L., Kočiš P. Biotransformation of stobadine, N-desmethylstobadine and gamma-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes. Xenobiotica. 17:1987;1067-1073.
113. Štefek M., Beneš L., Zelník V. N-Oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent. the role of flavin-containing monooxygenase Xenobiotica. 19:1989;143-150.
114. Štefek M., Masaryková M., Beneš L. Inhibition of cumene hydroperoxide-induced lipid peroxidation by a novel pyridoindole antioxidant in rat liver microsomes. Pharmac. Toxicol. 70:1992;407-411.
115. Štolc S. Effect of pyridoindole stobadine and verapamile on neuronal membrane ion channels (in Slovak). Čs. Fyziol. 39:1990;171.
116. Štolc S. Pyridoindole stobadine is a nonselective inhibitor of voltage-operated ion channels in rat sensory neurons. Gen. Physiol. Biophys. 13:1994;259-266.
117. 2 in rabbits (in Slovak). In Zborník Prác ÚEF SAV, (Edited by Beneš L.), Vol. 2, pp. 321-335. Veda Bratislava.
118. Štolc S. and Bauer V. (1980b) Antiarrhythmic effect of carbidine III: fibrillation threshold in the cat myocardium (in Slovak). In Zborník Prác ÚEF SAV, (Edited by Beneš L.), Vol. 2, pp. 347-358. Veda Bratislava.
119. Štolc S., Horáková L. Effect of stobadine on postischemic lipid peroxidation in the rat brain. Bartko D., Turčány P., Stern G. New Trends in Clinical Pharmacology. 1988;59-63 Libbey, London.
120. Štolc S., Selecká J. Protective effect of stobadine, a pyridoindole antioxidant, in hypoxia. reoxygenation injury of ganglionic and hippocampal neurotransmission Mol. Chem. Neuropathol. 25:1995;199-212.
121. Štolc S. and Vlkolinský R. (1995) Neurotransmission in rat hippocampus during hypoxia and reoxygenation in vitro: pharmacological protection. Pharmac. Res. 31(Suppl.), 295.
122. Štolc S., Bauer V., Beneš L. and Tichý (1983) Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: ČS 229 067, SWED. 8204693-9, BELG. 894148, SWISS 651 754, BRD P-323 1088, SPAIN 553 017, JAP. 151 4040.
123. Štolc S., Vlkolinský R., Pavlásek J. Neuroprotection by the pyridoindole stobadine. a minireview Brain Res. Bull. 42:1997;335-340.
124. Styk J., Gabauer I., Okoličány J., Holec V., Bauer V., Beneš L. Protective effect of stobadine (DH 1011) on the ischemic heart of the rat (in Slovak). Bratisl. Lek. Listy. 85:1986;274-281.
125. Szöcsová H., Beneš L. EPR study of stobadine free radicals generated by gamma irradiation in ethanol solution (in Slovak). Čs. Farm. 38:1989;121-123.
126. Ujházy E., Zeljenková D., Ďurišová M., Končeková Z., Miček J. Effect of pyridoindole derivative (DH 1011) on late chick embryogenesis. Anat. Anz. (Jena). 167:1988;113-117.
127. Ujházy E., Balonová T., Vargová T., Janšák J., Derková L'. Teratological study of stobadine after single and repeated administration in rats. Teratogen. Carcinogen. Mutagen. 12:1992;211-221.
128. Ujházy E., Faberová V., Zemánek M., Dubovický M., Janšák J. Maternal-fetal distribution of stobadine in rabbits. Teratology. 48:1993;40.
129. Ujházy E., Dubovický M., Balonová T., Janšák J., Zeljenková D. Teratological assessment of stobadine after single and repeated administration in mice. J. Appl. Toxicol. 14:1994;357-363.
130. Vinař O., Baxová V., Drábková D. General report on the results of the phase two clinical evaluation of the preparation stobadine (in Czech). Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium. 1987;2423-2430 Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic (data on file).
131. Vincenzi F. F., Rohn T. T., Clinch K. A. and Hinds T. R. (1993) Ion pumps: link between free radical mechanisms and in vivo effectiveness of protectant drugs?. In Int. Conf. on Critical Aspects of Free Radicals in Chemistry, Biochemistry and Medicine, p. 57. Veterinary Univ., Vienna, Austria.
132. Vlkolinský R. and Štolc S. (1996) Neuroprotectant stobadine does not act through excitatory amino acids antagonism: electrophysiological study on rat hippocampus in vitro. In Proc. of the 46th Pharmacol. Days, Universitas Palackiana, Olomouc, Czech Republic, p. 143. Czech Pharmacol. Soc., Olomouc.
133. Zeljenková D., Balonová T., Ujházy E., Navarová J., Mačičková T. Effect of new pyridoindole antiarrhythmic agents (DP 1031 and DH 1011) on embryogenesis in mice. teratological and biochemical study Plzeň. Lék. Sbor. Suppl. 53:1986;199-200.